GSK
GLAXOSMITHKLINE PLC ORD 25P
Stock London Stock Exchange – Stock Market Prices, News & Analysis
GlaxoSmithKline est une entreprise pharmaceutique mondiale, active dans la recherche, le développement, la fabrication et la distribution de médicaments, vaccins et produits de santé grand public.
GLAXOSMITHKLINE PLC ORD 25P
GSK
GlaxoSmithKline est une entreprise pharmaceutique mondiale, active dans la recherche, le développement, la fabrication et la distribution de médicaments, vaccins et produits de santé grand public.
Price history of GLAXOSMITHKLINE PLC ORD 25P
Price history of GLAXOSMITHKLINE PLC ORD 25P
Performance & Momentum
Strategic Analysis
GLAXOSMITHKLINE PLC ORD 25P • 2026
GlaxoSmithKline is a global pharmaceutical company positioned on an integrated model combining innovative medicines, vaccines, and consumer healthcare. Its strength lies in medical research expertise and sector diversification, enabling it to address a wide range of healthcare needs.
- Diversified portfolio including vaccines, medicines, and consumer products
- Sustained innovative capacity supported by significant R&D investment
- Global presence with a strong foothold in the United Kingdom and efficient coverage of key markets
- Exposure to stringent regulation and drug pricing pressure
- Dependence on a few flagship products for a significant share of revenue
Momentum is strong, driven by positive performance across multiple time horizons, reflecting renewed investor confidence in the company’s strategic repositioning and the group’s resilience, despite a demanding competitive and regulatory environment.
Similar stocks to GLAXOSMITHKLINE PLC ORD 25P
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
